Document Detail


Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs.
MedLine Citation:
PMID:  15999538     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Radiotherapy is effective for the palliation of pain associated with primary and metastatic bony neoplasia in dogs and humans, but no standard treatment protocol has been established. The goal of this study was to evaluate a 3 x 8 Gy and a 4 x 6 Gy protocol using electrons with a betatron or linear accelerator for the treatment of appendicular osteosarcoma in 54 dogs. Thirty-three dogs received chemotherapy consisting of carboplatin IV concurrently with radiotherapy. Eighty-three % (n = 45) of the dogs experienced pain relief during or following treatment. The median duration of pain relief from treatment start was 53 days. In conclusion, both protocols are effective for palliation of clinical signs of canine appendicular osteosarcoma. The outcome reported here is similar to the results of other studies using Co photons. The use of chemotherapy did not improve the response to radiotherapy.
Authors:
Fabienne Mueller; Valerie Poirier; Katja Melzer; Dagmar Nitzl; Malgorzata Roos; Barbara Kaser-Hotz
Related Documents :
8397928 - Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarc...
3965078 - Periosteal osteosarcoma.
15995158 - Influence of asparaginase on a combination chemotherapy protocol for canine multicentri...
20158328 - Vector control improves survival of three species of prairie dogs (cynomys) in areas co...
8137488 - Therapeutic effect of a cddp-epirubicin-lipiodol emulsion on advanced hepatocellular ca...
8198388 - Prognosis in congestive heart failure.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  In vivo (Athens, Greece)     Volume:  19     ISSN:  0258-851X     ISO Abbreviation:  In Vivo     Publication Date:    2005 Jul-Aug
Date Detail:
Created Date:  2005-07-07     Completed Date:  2005-08-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8806809     Medline TA:  In Vivo     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  713-6     Citation Subset:  IM    
Affiliation:
Section of Diagnostic Imaging and Radiation Oncology, Vetsuisse Faculty, University of Zürich, Switzerland. fmueller@vetclinics.unizh.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents
Bone Neoplasms / mortality,  pathology,  therapy,  veterinary*
Carboplatin / therapeutic use
Dog Diseases / drug therapy,  mortality,  pathology,  radiotherapy*
Dogs
Electrons / therapeutic use*
Female
Injections, Intravenous
Longevity / radiation effects
Male
Osteosarcoma / mortality,  secondary,  therapy,  veterinary*
Pain / therapy
Palliative Care*
Radiotherapy, Adjuvant / veterinary
Survival Rate
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 41575-94-4/Carboplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity.
Next Document:  Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of ...